Dublin, March 14, 2019 (GLOBE NEWSWIRE) -- The "Global E-Coli Partnering 2014-2019" report has been added to ResearchAndMarkets.com's offering.

The Global E-Coli Partnering Terms and Agreements since 2014 report provides understanding and access to partnering deals and agreements entered into by the world's leading healthcare companies.

The report provides an analysis of partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors technology. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes.

Understanding the flexibility of a prospective partner's negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to achieve during the negotiation of terms. Whilst many smaller companies will be seeking details of the payments clauses, the devil is in the detail in terms of how payments are triggered - contract documents provide this insight where press releases do not.

This data driven report contains multiple links to online copies of actual deals and contract documents as submitted to the Securities Exchange Commission by companies and their partners, where available. Contract documents provide the answers to numerous questions about a prospective partner's flexibility on a wide range of important issues, many of which will have a significant impact on each party's ability to derive value from the deal.

Global E-Coli Partnering Terms and Agreements since 2014 report provides the reader with the following key benefits:

• In-depth understanding of deal trends since 2014
• Access to headline, upfront, milestone and royalty data
• Comprehensive access to multiple deals entered into by the world's biopharma companies since 2014
• Insight into key deal terms included in contracts, where disclosed
• Understand the key deal terms companies have agreed in deals
• Undertake due diligence to assess suitability of your proposed deal terms for partner companies

Key Topics Covered:

Executive Summary

Chapter 1 - Therapy partnering trends in numbers

• Partnering in numbers - by year
• Partnering in numbers - most active
• Partnering in numbers - by industry sector
• Partnering in numbers - by deal type
• Partnering in numbers - by technology type
• Partnering in numbers - by stage of development

Chapter 2 - Most active dealmakers

Chapter 3 - Partnering deals directory

• Partnering deals directory - by company A-Z
• Partnering deals directory - by deal value
• Partnering deals directory - by industry sector
• Partnering deals directory - by deal type
• Partnering deals directory - by stage of development
• Partnering deals directory - by technology area

Chapter 4 - Partnering deals with a contract document

For more information about this report visit https://www.researchandmarkets.com/research/hxpsz9/global_ecoli?w=12

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

CONTACT: ResearchAndMarkets.com
         Laura Wood, Senior Press Manager
         press@researchandmarkets.com
         For E.S.T Office Hours Call 1-917-300-0470
         For U.S./CAN Toll Free Call 1-800-526-8630
         For GMT Office Hours Call +353-1-416-8900
Related Topics: Infectious Diseases Drugs

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.